Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Intangibles: 2018-2025

Historic Intangibles for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $1.1 billion.

  • Dr Reddys Laboratories' Intangibles rose 155.98% to $1.1 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $1.1 billion, marking a year-over-year increase of 155.98%. This contributed to the annual value of $1.1 billion for FY2025, which is 155.98% up from last year.
  • Dr Reddys Laboratories' Intangibles amounted to $1.1 billion in FY2025, which was up 155.98% from $443.0 million recorded in FY2024.
  • Dr Reddys Laboratories' 5-year Intangibles high stood at $1.1 billion for FY2025, and its period low was $359.0 million during FY2022.
  • In the last 3 years, Dr Reddys Laboratories' Intangibles had a median value of $443.0 million in 2024 and averaged $650.7 million.
  • Its Intangibles has fluctuated over the past 5 years, first fell by 26.28% in 2022, then surged by 155.98% in 2025.
  • Yearly analysis of 5 years shows Dr Reddys Laboratories' Intangibles stood at $487.0 million in 2021, then fell by 26.28% to $359.0 million in 2022, then grew by 4.46% to $375.0 million in 2023, then climbed by 18.13% to $443.0 million in 2024, then soared by 155.98% to $1.1 billion in 2025.